Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line (Q46856662)
Jump to navigation
Jump to search
scientific article published in December 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line |
scientific article published in December 2005 |
Statements
1 reference
Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line (English)
1 reference
1 reference
Axel Grothey
1 reference
1 December 2005
1 reference
1 reference
23
1 reference
9441-9442
1 reference
36
1 reference
Identifiers
1 reference
1 reference